Australia’s newest online retailer raises the bar for affordability and philanthropy that is set to challenge other shopping giants.
House of Josh was launched with one vision – to make online shopping affordable while proving that businesses can still have a social conscience. And the first sector of the community to benefit are children diagnosed with cancer.
More than 950 children 0 – 19 years of age are diagnosed with cancer every year in Australia. House of Josh has stepped up to make a genuine difference in their lives by supporting medical research to find better treatments.
Adam Racomelara, founder and CEO of the online store styled as ‘the house of smiles’, has pledged to donate 10 per cent of all sales to The Kids’ Cancer Project, an independent national charity supporting ground-breaking scientific research in institutes all around the country.
“We’re giving more back than any other retailer in Australia and, as far as we know, the rest of the world too! We want to show the big boys how it’s done,” said Racomelara.
Owen Finegan, CEO of The Kids’ Cancer Project, welcomes the commitment to childhood cancer research as part of the retailer’s desire to give back to the community.
“We are grateful that Adam and his team are inspired to ensure research continues to find kinder, more effective treatments for all children with cancer,” said Finegan. “Our mission is to support bold science that will lead to the one hundred per cent survival of all children diagnosed with the disease.”
“We’re looking forward to putting the House of Josh investment to work and reporting back on the impact of their contribution,” he said.
House of Josh has a range of homewares along with products in the beauty, sport and pet categories. Shoppers can purchase discounted items from familiar brands including Sleepy Panda, Ergopedic, Royal Comfort, Glow by Beca, Australian Leather, Havaianas, KISS Cosmetics, Buddy Scrub and more. Visit houseofjosh.com to shop now.
Donate to research and help find more effective treatments for kids with cancer.